Publication in refereed journal
香港中文大学研究人员 ( 现职)
| 马碧如教授 (肿瘤学系) |
| 陈德章教授 (肿瘤学系) |
全文
典藏于此文库的全文
数位物件识别号 (DOI) http://dx.doi.org/10.1200/JCO.2015.60.9347 |
引用次数
Scopushttp://aims.cuhk.edu.hk/converis/portal/Publication/39Scopus source URL
其它资讯
摘要Nasopharyngeal carcinoma of the undifferentiated subtype is endemic to southern China, and patient prognosis has improved significantly over the past three decades because of advances in disease management, diagnostic imaging, radiotherapy technology, and broader application of systemic therapy. Despite the excellent local control with modern radiotherapy, distant failure remains a key challenge. Advances in molecular technology have helped to decipher the molecular pathogenesis of nasopharyngeal carcinoma as well as its etiologic association with the Epstein-Barr virus. This in turn has led to the discovery of novel biomarkers and drug targets, rendering this cancer site a current focus for new drug development. This article reviews and appraises the key literature on the current management of nasopharyngeal carcinoma and future directions in clinical research.
着者Lee AW, Ma BB, Ng WT, Chan AT
期刊名称Journal of Clinical Oncology
出版年份2015
月份10
日期10
卷号33
期次29
出版社American Society of Clinical Oncology
页次3356 - 3364
国际标準期刊号0732-183X
电子国际标準期刊号1527-7755
语言美式英语
关键词Nasopharyngeal Carcinoma
